Genetic testing for both KRAS and BRCA mutations in patients with family history or who are at high risk of pancreatic cancer
Screening
Screening should be at age 50 years in patients who are at high risk for pancreatic cancer, or when they are 10 years younger than their youngest affected relative
Diabetes (Type 3c)- a type of diabetes that develops when another disease causes damage to the pancreas.
Please talk to your healthcare professional (i.e. Medical Doctor/Pharmacist) for further advice
Detailed Information
Please copy and paste any key words from the title: Pancreatic Cancer in the following respective 'Medtick References and/or Sources' to find out more about the disease (this also may include diagnosis tests and generic medical treatments).
The Pharmaceutical Journal covers analysis, features, opinion, learning and careers articles, providing insight and knowledge about drugs, pharmacy practice, medicines use and healthcare policy in the context of the pharmacy profession and pharmaceutical science.